{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:18:45Z","timestamp":1790230725765,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajkd.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1053\/j.ajkd.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T10:31:28Z","timestamp":1505989888000},"page":"859-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report"],"prefix":"10.1053","volume":"70","author":[{"given":"Vinod K.","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard G.","family":"Jaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 suppl 2","key":"10.1053\/j.ajkd.2017.08.003_bib1","first-page":"S15","article-title":"NKF-DOQI clinical practice guidelines for hemodialysis adequacy","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"4 suppl 3","key":"10.1053\/j.ajkd.2017.08.003_bib2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2017.08.003_bib3","first-page":"S1","article-title":"US Renal Data System 2015 annual data report: epidemiology of kidney disease in the United States","volume":"67","author":"Saran","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.ajkd.2013.10.013","article-title":"Risk of stroke in long-term dialysis patients compared with the general population","volume":"63","author":"Wang","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"10.1053\/j.ajkd.2017.08.003_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2017.08.003_bib6","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2010050459","article-title":"The increasing prevalence of atrial fibrillation among hemodialysis patients","volume":"22","author":"Winkelmayer","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2004.12.048","article-title":"Frequency of atrial fibrillation and factors related to its development in dialysis patients","volume":"106","author":"Atar","year":"2006","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib9","first-page":"234","article-title":"Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients","volume":"54","author":"Fabbian","year":"2000","journal-title":"Clin Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2017.08.003_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.2009.185","article-title":"Atrial fibrillation in incident dialysis patients","volume":"76","author":"Vazquez","year":"2009","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08860220701191237","article-title":"Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis","volume":"29","author":"Bozbas","year":"2007","journal-title":"Ren Fail"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.003_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2005.07.044","article-title":"Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients","volume":"46","author":"Genovesi","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.ajkd.2007.10.034","article-title":"Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients","volume":"51","author":"Genovesi","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2017.08.003_bib15","first-page":"1409","article-title":"Echocardiographic associates of atrial fibrillation in end-stage renal disease","volume":"32","author":"Hensen","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2017.08.003_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/heartjnl-2013-305417","article-title":"The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients","volume":"100","author":"Buiten","year":"2014","journal-title":"Heart"},{"key":"10.1053\/j.ajkd.2017.08.003_bib17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1540-8159.2007.00877.x","article-title":"Atrial fibrillation in end-stage renal disease","volume":"30","author":"Korantzopoulos","year":"2007","journal-title":"Pacing Clin Elecrophysiol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1081\/JDI-100001285","article-title":"Symptomatic atrial arrythmias in hemodialysis patients","volume":"23","author":"Ansari","year":"2001","journal-title":"Renal Failure"},{"issue":"6","key":"10.1053\/j.ajkd.2017.08.003_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s11255-017-1506-1","article-title":"The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis","volume":"49","author":"Franczyk","year":"2017","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfu412","article-title":"Warfarin therapy for atrial fibrillation in haemodialysis patients: mind the (evidence) gap","volume":"30","author":"Szummer","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2017.08.003_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib22","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"10","key":"10.1053\/j.ajkd.2017.08.003_bib23","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1053\/j.ajkd.2017.08.003_bib24","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","article-title":"Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project)","volume":"32","author":"Lamassa","year":"2001","journal-title":"Stroke"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end-stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2017.08.003_bib27","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1681\/ASN.2012080841","article-title":"Incidence of stroke before and after dialysis initiation in older patients","volume":"24","author":"Murray","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.ajkd.2009.01.261","article-title":"Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study","volume":"54","author":"Sozio","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000068034","article-title":"Silent cerebral infarction in hemodialysis patients","volume":"23","author":"Nakatani","year":"2003","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.ajkd.2012.08.035","article-title":"Anatomic brain disease in hemodialysis patients: a cross-sectional study","volume":"61","author":"Drew","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semnephrol.2015.06.003","article-title":"Stroke and chronic kidney disease: epidemiology, pathogenesis, and management across kidney disease stages","volume":"35","author":"Dad","year":"2015","journal-title":"Semin Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.ackd.2008.01.010","article-title":"Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden","volume":"15","author":"Murray","year":"2008","journal-title":"Adv Chronic Kidney Dis"},{"issue":"22","key":"10.1053\/j.ajkd.2017.08.003_bib33","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib35","doi-asserted-by":"crossref","first-page":"e000250","DOI":"10.1161\/JAHA.113.000250","article-title":"A\u00a0new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.112.107128","volume":"127","author":"Piccini","year":"2013","journal-title":"Circulation"},{"issue":"16","key":"10.1053\/j.ajkd.2017.08.003_bib37","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cjca.2014.01.005","article-title":"R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score","volume":"30","author":"Chao","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.ajkd.2017.08.003_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijcard.2016.11.015","article-title":"Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation","volume":"227","author":"Zhu","year":"2017","journal-title":"Int J Cardiol"},{"issue":"23","key":"10.1053\/j.ajkd.2017.08.003_bib40","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cjca.2016.08.018","article-title":"Are existing risk scores for nonvalvular atrial fibrillation useful for prediction or risk adjustment in patients with chronic kidney disease?","volume":"33","author":"McAlister","year":"2017","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1053\/j.ajkd.2017.08.003_bib42","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1681\/ASN.2013060601","article-title":"Assessment and management of hypertension in patients on dialysis","volume":"25","author":"Agarwal","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2017.08.003_bib43","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2215\/CJN.03200316","article-title":"Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: con","volume":"11","author":"Keskar","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2017.08.003_bib44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.114.014113","article-title":"Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis","volume":"131","author":"Chan","year":"2015","journal-title":"Circulation"},{"issue":"12","key":"10.1053\/j.ajkd.2017.08.003_bib45","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.ajkd.2007.06.017","article-title":"Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates","volume":"50","author":"Elliott","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2017.08.003_bib47","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mhj.2000.111111","article-title":"Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis","volume":"140","author":"Vazquez","year":"2000","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.ajkd.2017.08.003_bib48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0002-9149(03)00904-4","article-title":"Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis","volume":"92","author":"Vazquez","year":"2003","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000046216","article-title":"Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation","volume":"21","author":"Wiesholzer","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2017.08.003_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-4-1","article-title":"Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality","volume":"4","author":"Abbott","year":"2003","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.003_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1440-1797.2007.00835.x","article-title":"Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?","volume":"12","author":"To","year":"2007","journal-title":"Nephrology (Carlton)"},{"issue":"10","key":"10.1053\/j.ajkd.2017.08.003_bib52","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2017.08.003_bib53","first-page":"33","article-title":"Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin","volume":"2","author":"Lai","year":"2009","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ndt\/gfr341","article-title":"Coumarins and survival in incident dialysis patients","volume":"27","author":"Knoll","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2017.08.003_bib55","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.113.004777","article-title":"Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis","volume":"129","author":"Shah","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.003_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/europace\/euv289","article-title":"Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis","volume":"18","author":"Chan","year":"2016","journal-title":"Europace"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ndt\/gfu334","article-title":"Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation","volume":"30","author":"Genovesi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.003_bib58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10157-015-1205-0","article-title":"Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study","volume":"20","author":"Hayashi","year":"2016","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2015.05.019","article-title":"Outcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillation","volume":"66","author":"Shen","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.hlc.2015.08.012","article-title":"Relationships between anticoagulation, risk scores and adverse outcomes in dialysis patients with atrial fibrillation","volume":"25","author":"Wang","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"12","key":"10.1053\/j.ajkd.2017.08.003_bib61","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00380-016-0818-x","article-title":"Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry","volume":"31","author":"Yamashita","year":"2016","journal-title":"Heart Vessels"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib62","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12882-016-0368-6","article-title":"Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis","volume":"17","author":"Tan","year":"2016","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.08.003_bib64","doi-asserted-by":"crossref","first-page":"e2741","DOI":"10.1097\/MD.0000000000002741","article-title":"Warfarin use and risk of stroke in patients with atrial fibrillation undergoing hemodialysis: a meta-analysis","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"50","key":"10.1053\/j.ajkd.2017.08.003_bib65","doi-asserted-by":"crossref","first-page":"e2233","DOI":"10.1097\/MD.0000000000002233","article-title":"Effectiveness and safety of warfarin in dialysis patients with atrial fibrillation: a meta-analysis of observational studies","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.ajkd.2017.08.003_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40697-014-0021-x","article-title":"The three-year incidence of major hemorrhage among older adults initiating chronic dialysis","volume":"1","author":"Sood","year":"2014","journal-title":"Can J Kidney Health Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib67","first-page":"235","article-title":"Gastrointestinal bleeding in patients on long-term dialysis","volume":"28","author":"Trivedi","year":"2015","journal-title":"J\u00a0Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib68","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1681\/ASN.2008070802","article-title":"Kidney function influences warfarin responsiveness and hemorrhagic complications","volume":"20","author":"Limdi","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2017.08.003_bib69","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2215\/CJN.04550511","article-title":"Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2017.08.003_bib70","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1681\/ASN.2015050535","article-title":"The risk of major hemorrhage with CKD","volume":"27","author":"Molnar","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.003_bib71","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib72","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib74","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ki.2013.170","article-title":"Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS","volume":"84","author":"Sood","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5021\/ad.2014.26.1.96","article-title":"Warfarin-induced skin necrosis","volume":"26","author":"Kakagia","year":"2014","journal-title":"Ann Dermatol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib76","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2017.08.003_bib77","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1681\/ASN.2015091065","article-title":"A\u00a0nationally representative study of calcific uremic arteriolopathy risk factors","volume":"27","author":"Nigwekar","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib78","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","article-title":"Risk factors and mortality associated with calciphylaxis in end-stage renal disease","volume":"60","author":"Mazhar","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.114.304793","article-title":"Conflicting forces of warfarin and matrix gla protein in the artery wall","volume":"35","author":"Demer","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1053\/j.ajkd.2017.08.003_bib80","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/ndt\/gfu224","article-title":"The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: a longitudinal study","volume":"29","author":"Mac-Way","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2017.08.003_bib81","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ki.2012.477","article-title":"Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease","volume":"83","author":"McCabe","year":"2013","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2017.08.003_bib82","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40697-015-0053-x","article-title":"Inhibiting the progression of arterial calcification with vitamin K in hemodialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage\u00a0kidney disease","volume":"2","author":"Holden","year":"2015","journal-title":"Can J Kidney Health Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib83","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.devcel.2012.02.005","article-title":"ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway","volume":"22","author":"Larrivee","year":"2012","journal-title":"Dev Cell"},{"issue":"47","key":"10.1053\/j.ajkd.2017.08.003_bib84","doi-asserted-by":"crossref","first-page":"19071","DOI":"10.1073\/pnas.1310905110","article-title":"Reducing jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix Gla protein deficiency","volume":"110","author":"Yao","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ki.2015.298","article-title":"Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?","volume":"89","author":"Zaragatski","year":"2016","journal-title":"Kidney Int"},{"issue":"16","key":"10.1053\/j.ajkd.2017.08.003_bib86","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib87","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5414\/CN106481","article-title":"Warfarin use in hemodialysis patients: what is the risk?","volume":"75","author":"Phelan","year":"2011","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib88","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2007111207","article-title":"Dilemmas in the management of atrial fibrillation in chronic kidney disease","volume":"20","author":"Reinecke","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2017.08.003_bib89","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2017.08.003_bib90","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.jacc.2016.02.082","article-title":"Nonvitamin K anticoagulant agents in patients with advanced chronic kidney disease or on dialysis with AF","volume":"67","author":"Chan","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.08.003_bib91","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13318-011-0037-x","article-title":"Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor","volume":"36","author":"He","year":"2011","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"11","key":"10.1053\/j.ajkd.2017.08.003_bib92","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2017.08.003_bib93","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1177\/1060028014554446","article-title":"Apixaban use among patients with severe renal impairment","volume":"48","author":"Deal","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1053\/j.ajkd.2017.08.003_bib94","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1681\/ASN.2016090980","article-title":"Apixaban pharmacokinetics at steady state in hemodialysis patients","volume":"28","author":"Mavrakanas","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2017.08.003_bib95","unstructured":"US Food and Drug Administration. Eliquis (apixaban) tablets. https:\/\/www.fda.gov\/downloads\/drugs\/drugsafety\/ucm333961.pdf. Accessed November 21, 2016."},{"issue":"10","key":"10.1053\/j.ajkd.2017.08.003_bib96","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2017.08.003_bib97","unstructured":"US Food and Drug Administration. Xarelto (rivaroxaban) tablets. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022406s001s002s003mg.pdf. Accessed December 8,\u00a02016."},{"issue":"4","key":"10.1053\/j.ajkd.2017.08.003_bib98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000445328","article-title":"Pharmacokinetics, pharmacodynamics, and safety of single-dose rivaroxaban in chronic hemodialysis","volume":"43","author":"Dias","year":"2016","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2017.08.003_bib99","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.103.1.163","article-title":"Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association","volume":"103","author":"Goldstein","year":"2001","journal-title":"Circulation"},{"issue":"8631","key":"10.1053\/j.ajkd.2017.08.003_bib100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"issue":"22","key":"10.1053\/j.ajkd.2017.08.003_bib101","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib102","first-page":"527","article-title":"Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"issue":"20","key":"10.1053\/j.ajkd.2017.08.003_bib103","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2017.08.003_bib104","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) Study","volume":"18","author":"Connolly","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.08.003_bib105","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2017.08.003_bib106","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cjca.2016.07.591","article-title":"2016 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"}],"updated-by":[{"DOI":"10.1053\/j.ajkd.2019.01.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000}}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:12:37Z","timestamp":1659499957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638617308880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0272638617308880"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.003","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}